![](https://www.diabetesnews.com/wp-content/uploads/2013/07/glioblastoma-xenograft-model-nu0901-5-2col-150x150.jpg)
Kamada Ltd. have announced that favorable results from a preclinical study analyzing the effects of the Company’s human Alpha-1 Antitrypsin (AAT), Glassia, in inter-species islet graft transplantation were published in PLOS One
Read more
Kamada Ltd. have announced that favorable results from a preclinical study analyzing the effects of the Company’s human Alpha-1 Antitrypsin (AAT), Glassia, in inter-species islet graft transplantation were published in PLOS One
Read more